← back to search

Yu Zhang

Guangzhou University of Chinese Medicine · CN
Area of research
Immunology · Oncology
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Phagocytosis and Immune Regulation, and CAR-T cell therapy research.
h-index
31
citations
6,530
works
100
NIH funding
primary concept
email

Recent publications

Cancer immunology data engine reveals secreted AOAH as a potential immunotherapy
Cell 2025cited by 27position: middledoi
Extra-skeletal Ewing’s sarcoma with EWSR1::ERG translocation of the breast: a case report
Diagnostic Pathology 2025cited by 0position: lastdoi
FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
Cancer Research 2024cited by 89position: middledoi
Estimation of cell lineages in tumors from spatial transcriptomics data
Nature Communications 2023cited by 116position: middledoi
Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction
Nature Communications 2023cited by 113position: middledoi
Enhanced mitophagy driven by ADAR1-GLI1 editing supports the self-renewal of cancer stem cells in HCC
Hepatology 2023cited by 38position: middledoi
A T cell resilience model associated with response to immunotherapy in multiple tumor types
Nature Medicine 2022cited by 62position: firstdoi
Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research 2022cited by 37position: middledoi
Systematic investigation of cytokine signaling activity at the tissue and single-cell levels
Nature Methods 2021cited by 251position: middledoi
Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma
Nature Communications 2021cited by 211position: middledoi
Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor
Oncogene 2021cited by 43position: middledoi
FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma
Theranostics 2020cited by 168position: middledoi
C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism
Oncogene 2020cited by 89position: firstdoi
A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets
Proceedings of the National Academy of Sciences 2020cited by 72position: middledoi
Recurrent ZNF83-E293V Mutation Promotes Bladder Cancer Progression through the NF-κB Pathway via Transcriptional Dysregulation of S100A8
Molecular Therapy 2020cited by 55position: middledoi
ZIC2 is downregulated and represses tumor growth <i>via</i> the regulation of STAT3 in breast cancer
International Journal of Cancer 2020cited by 42position: middledoi
Role of YAP-related T cell imbalance and epidermal keratinocyte dysfunction in the pathogenesis of atopic dermatitis
Journal of Dermatological Science 2020cited by 20position: middledoi
QUBIC2: a novel and robust biclustering algorithm for analyses and interpretation of large-scale RNA-Seq data
Bioinformatics 2019cited by 69position: middledoi
<i>ANGPTL1</i> Interacts with Integrin α1β1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling
Cancer Research 2017cited by 73position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xin‐Yuan Guan · Chongqing Jiaotong University12 papers (2017–2025)Lanqi Gong · New York University9 papers (2020–2025)Qian Yan · Sun Yat-sen University6 papers (2017–2022)Xiaona Fang · Sun Yat-sen University6 papers (2020–2024)Ying Tang · Fudan University5 papers (2020–2023)Jinlin Huang · Geisinger Medical Center5 papers (2021–2024)Beilei Liu · City University of Hong Kong5 papers (2020–2024)Baifeng Zhang · Ningbo University5 papers (2021–2024)Jie Luo · Fujian Agriculture and Forestry University4 papers (2022–2024) · 4 papers (2020–2023)Jiao Huang · Sun Yat-sen University Cancer Center4 papers (2022–2024)Peng Jiang · Chinese Academy of Medical Sciences & Peking Union Medical College4 papers (2021–2025)Dandan Yu · Uppsala University3 papers (2017–2021)Rohit Paul · Center for Cancer Research3 papers (2021–2025)Trang Vu · Center for Cancer Research3 papers (2021–2025)Kenneth Aldape · National Institute of Mental Health3 papers (2022–2025)Beibei Ru · University of Electronic Science and Technology of China3 papers (2021–2025)Zhaojie Lyu · Ministry of Education of the People's Republic of China3 papers (2020–2020) · 3 papers (2020–2024)Shanshan Li · Tianjin University of Traditional Chinese Medicine3 papers (2021–2023)